AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 30 Sep 2019. The tender notice number is 279950-2017, while the TOT Ref Number is 14997081. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 30 Sep 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 14997081

Document Ref. No. : 279950-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK PLUS - DIE GESUNDHEITSKASSE FÜR SACHSEN UND THÜRINGEN
Office Name: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Address: Augustinerstraße 38
Town: Erfurt
Postal Code: 99084
Contact Point: Unternehmensbereich Corporate Governance, Geschäftsbereich Zentrale Vergabestelle
Attention: Herrn Rechtsanwalt Sören Rabe


Germany
Email :vergabestelle@plus.aok.de
URL :https://plus.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Not specified
CPV code: 33600000, 33600000
CPV Description: Conclusion of non-exclusive discount agreements pursuant to - 130a para. 8 SGB V with the possibility to enter into an open-house model within the period from 16.8.2017 to 30.9.2019 for medicines for the active substance combination valsartan / amlodipine (ATC code According to WHO: C09DB01).

Pharmaceutical products.

The subject of this publication is the conclusion of a discount agreement(ATC code according to WHO: C09DB01) within the framework of an "open-house model" according to section 130a (8) SGB V for medicinal products for the active substance combination Valsartan / amlodipine The access to a discount agreement pursuant to section 130a para. 8 SGB V offersN. An exclusivity is not given. At the time of the conclusion of the agreement, the amount of waste is unknown, and in particular depends on the demand of the insured persons, the development of the number of insured persons, the regulation behavior of the contracting parties and the dispensing and stockholding behavior of the public pharmacies. The client does not guarantee minimum acceptance quantitiesOf the agreement may be made at any time and under the same conditions. No specific contract negotiations will be carried out.

Interested pharmaceutical companies can request the participation documents (discount agreement and the form mentioned under III.2.1) via the e-mail address given under I.1). 2017-Closed until 30.9.2019. Interested parties are required to submit the fully completed and signed participation documents (declaration of non-existence of exclusions and discount agreement) to 15.8.2017 for the first time and then to the 15th of a month at the address mentioned under I.1). Access to the AOK PLUS is available. If the 15th of a month falls on a sonnaBend, Sunday or federal holiday, the next working day shall be replaced by such day. The discount agreement enters into force by signing the AOK PLUS. The signing will take place until the end of the month in which the attendance documents have been received by AOK PLUS. In case of later receipt (after 15.8.2017 or after the 15th of a month)-























































Organizationally, a preliminary round of about half a month is required by the AOK PLUS to make the declarations of the discount agreement. The initial labeling of the discount medicines in the pharmacy software will take place from the second month, Which follows the date of receipt of the participation documents. In the case of changes or revisions of the deadlines for the deadline reporting in the nationwide AOK contract reporting portal DatRabatt, this date may vary.

With all pharmaceutical entrepreneurs fulfilling the conditions of participation and confirming this by signing on the requested documents, The contract shall end no later than 30.09.2019, irrespective of the date of conclusion of the contract. The AOK PLUS The health insurance fund for Saxony and Thueringen has the right to replace the non-exclusive open-house discount agreements by exclusive discount agreements during the term of the agreement. With the entry into force, exclusive discountThe open-house agreements are automatically terminated. The present open-house procedure is terminated in this case. According to the experience of the AOK PLUS, exclusive rebate agreements come into force usually eight to twelve months after the publication of the corresponding notice notice in the Supplement to the Official Journal of the European Union. The future treatyArtners in the open-house model are asked to be regularly informed about this in the Supplement to the Official Journal of the European Union. Note: This publication is not a public procurement contract in the sense of the Guideline (2014/24 / EU) ) Or of the right to rectify the dispute. In order to ensure the widest degree of transparency for the intended contractors, The publication is published in the Supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice shall be used. The resulting conceptual specifications, such as, for example, the procedure description "open procedure", are solely for the use of this publication form and the authoritiesTion platform. A further meaning, in particular a submission under the rules of the law, to the extent that they are not compulsory for legal reasons, is not connected with this
Internet address (URL): https://plus.aok.de
Directive: Classical Directive (2004/18/EC)

Documents

 Tender Notice